Indonesia Set to Be Southeast Asia's mRNA Vaccine Base

The World Health Organization (WHO) establishes a global bio-manufacturing training center in South Korea. It operates as a learning center for developing countries wanting to be self-sufficient in producing biological products, such as vaccines, insulin shots, monoclonal antibodies, and cancer treatments. The WHO stated that Indonesia was one of the countries picked to conduct a technology transfer to manufacture COVID-19 vaccines using the mRNA platform.

WHO Director-General Tedros Adhanom Ghebreyesus was sure that the method would be suitable for poor and developing countries since they could learn to produce such health products according to good quality standards. "So they no longer have to wait in the queue," Ghebreyesus said on Wednesday. The WHO will prioritize countries unfamiliar with the mRNA technology but already have the infrastructure and bio-manufacturing capacity. However, WHO will also welcome other countries interested in adopting the technology.